Finance

Beta
Lists
IRMD:NASDAQ
Iradimed Corp
$98.04
+2.60%
(+2.48) 1D
$98.04
0.00% (0.00)
After hours
Closed: Jul 1, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IRMD...
Open
$96.10
High
$99.10
Low
$94.80
Mkt. cap
1.25B
Avg. vol.
151.84K
Volume
154.91K
Dividend
0.82%
Quarterly dividend
$0.20
Ex-dividend date
May 15, 2026
P/E ratio
53.42
52-wk high
$107.90
52-wk low
$55.11
EPS
$1.84
Beta
0.89
Shares outstanding
12.78M
No. of employees
166
Open
$96.10
High
$99.10
Low
$94.80
Mkt. cap
1.25B
Avg. vol.
151.84K
Volume
154.91K
Dividend
0.82%
Quarterly dividend
$0.20
Ex-dividend date
May 15, 2026
P/E ratio
53.42
52-wk high
$107.90
52-wk low
$55.11
EPS
$1.84
Beta
0.89
Shares outstanding
12.78M
No. of employees
166
News stories
From sources across the web
About Iradimed Corp
CEO-
Employees166
Founded1992
HeadquartersOrlando, Florida, United States
SectorMedical device
Websiteiradimed.com
Analyst ratings
Based on 1 analyst giving stock ratings to IRMD in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for IRMD in the last 3 months
Highest
Current $98.04
$116.00 (+18.32%)
Average
$116.00 (+18.32%)
Lowest
$116.00 (+18.32%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
$116.00
+18.3%
04/02/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$120.00
+22.4%
02/11/2026
Kyle Bauser
Roth MKM
Buy
Reiterated
$120.00
+22.4%
02/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
20.41M
21.20M
22.69M
21.98M
Cost of goods sold
4.45M
4.71M
5.66M
5.16M
Cost of revenue
4.45M
4.71M
5.66M
5.16M
Research and development expenses
868.20K
674.36K
775.03K
956.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.30M
8.99M
9.16M
8.62M
Operating expense
9.17M
9.66M
9.94M
9.58M
Total operating expenses
13.62M
14.37M
15.60M
14.74M
Operating income
6.79M
6.83M
7.09M
7.24M
Other non operating income
539.25K
463.98K
-1.52M
532.00K
EBT including unusual items
7.33M
7.30M
7.79M
7.77M
EBT excluding unusual items
7.33M
7.30M
7.59M
7.77M
Income tax expense
1.55M
1.72M
1.35M
1.95M
Effective tax rate
21.20%
23.58%
17.31%
25.11%
Other operating expenses
-
-
-
-
Net income
5.77M
5.58M
6.44M
5.82M
Net profit margin
28.29%
26.30%
28.39%
26.47%
Earnings per share
0.49
0.47
0.54
0.49
Interest and investment income
-
-
2.01M
-
Interest expense
-
-
-
-
Net interest expenses
-
-
2.01M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
7.00M
7.22M
7.47M
7.69M
Gain or loss from assets sale
1.16K
32.99K
2.85K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer